Lumida
/TDOC
⌘K
Teladoc Health Inc

Teladoc Health Inc

TDOC
$9.43USD-0.42%-0.04 today

MARKET CAP

1.7B

P/E (TTM)

FWD P/E

DAY RANGE

$9 – $9

52W RANGE

$4
$10

AI Summary

Stalk
StalkMedium

Despite strong acceleration signaled by the active Parabola pattern within a Stage 2 advance, price is extended and overbought above key EMAs. With a bearish long-term trend anchoring structural polarity, we defer entry and stalk for pullbacks into the rising EMA support zone (9/20), where a hold would confirm continuation participation.

  • Integrated care revenue rose 2% YoY to $391M as membership hit 102.5M
  • BetterHelp insurance sessions at 14K/week deliver a $75M run rate, targeting $125M by 2026
  • Net loss of $0.36 per share and negative earnings yield highlight unprofitable operations
Full analysis →

The case for & against

Bull & Bear analysis

Bearish

Teladoc Health, Inc. (NYSE: TDOC) is a leader in telehealth services, providing a comprehensive range of integrated healthcare solutions that span mental health, chronic condition management, and urgent care. The company is strategically positioned to capitalize on the growing demand for telehealth, particularly with recent expansions into insurance coverage and the integration of advanced AI technologies into its service offerings. This positions Teladoc in a favorable light amidst the broader healthcare push towards digital transformation and enhanced patient engagement.

Bull says

  • Integrated care revenue rose 2% YoY to $391M as membership hit 102.5M
  • BetterHelp insurance sessions at 14K/week deliver a $75M run rate, targeting $125M by 2026
  • Q1 cash balance of $751M provides funding flexibility for growth and debt management
  • High analyst revisions reflect rising earnings expectations and positive market sentiment
  • Book-to-price above 1.4 and strong liquidity signal potential undervaluation and operational flexibility
  • AI integration plus Catapult Health, BetterHelp and Uplift acquisitions underpin future service differentiation

Bear says

  • Net loss of $0.36 per share and negative earnings yield highlight unprofitable operations
  • BetterHelp revenue declined 9% YoY, exposing headwinds in mental health segment
  • Transition to visit-based model risks revenue instability amid subscription declines
  • High volatility and negative growth and profitability factors signal elevated market and slowdown risks
  • Intense competition from Amwell, Headspace and MDLive threatens market share
  • Weak profitability metrics and growth outlook may deter risk-averse investors

Investment themes with TDOC

Health Care Providers -0.61%

UNH · CVS · HCA

Earnings Call · Q1 2026 · Mgmt. Guidance

Updated 05-01-2026neutral

Transcript signals

Bull points

  • I'm pleased with our performance for the quarter, with consolidated revenue and adjusted EBITDA both exceeding the midpoint of our guidance ranges and reflecting solid performance in integrated care and progress we're making in scaling insurance to better health.
  • We see our ability to provide more comprehensive care at scale positioning us well for the opportunities ahead.
  • Multiple health plans have added the enhanced offering already, and we expect more to follow suit.

Bear points

  • Mental health conditions impact over 60 million adults in the U.S., with half of those not receiving treatment, and over a third of the U.S. population living in areas with a shortage of mental health professionals.
  • BetterHelp's first quarter revenue was $218 million, 9% lower than the prior year period, reflecting continued pressure on the direct-to-consumer cash-paid business.
  • Average paying users declined 9% from the prior year's quarter to 361,000, reflecting a mid-teens decline in the U.S., partially offset by high single-digit growth in non-U.S. markets.
Read full transcript analysis ›